Nebraska Medicine Hematology/Oncology

www.nebraskamed.com

 

Curative Strategy for High-Risk Smoldering Myeloma, Consolidation Therapy for NDMM & Cost and Quality of Anti-Resorptive Agents

225 views
March 9, 2020
Comments 0
Login to view comments. Click here to Login